InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
17%
T+90 mean return
-34.9%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Mauro David J, Directeur Médical. Insider active across 3 companies, notably Prelude Therapeutics Inc. Cumulatively, 19 filings have been published. History available since 5 May 2021. The latest transaction was disclosed on 15 November 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations19 total
4,187 shares@ US$6.17520.7% of flowClass A Common StockSEC:0001601830-24-000215:0
14,146 shares@ US$6.6972.6% of flowClass A Common StockSEC:0001601830-24-000127:0
867 shares@ US$10.016.7% of flowClass A Common StockSEC:0001601830-24-000058:0
6,040 shares0Class A Common StockSEC:0001209191-24-003241:0
190,713 shares0Class A Common StockSEC:0001209191-23-035239:0
15,000 shares@ US$1.898.5% of flowCommon StockSEC:0001209191-21-059850
15,000 shares@ US$1.890.0069% mcap8.5% of flowCommon StockSEC:0001209191-21-059850:0
15,000 shares@ US$1.890.0067% mcap8.4% of flowCommon StockSEC:0001209191-21-055307:0
15,000 shares@ US$1.898.4% of flowCommon StockSEC:0001209191-21-055307
15,000 shares@ US$1.890.0067% mcap8.4% of flowCommon StockSEC:0001209191-21-050404:0
15,000 shares@ US$1.898.4% of flowCommon StockSEC:0001209191-21-050404
15,000 shares@ US$1.890.0067% mcap8.4% of flowCommon StockSEC:0001209191-21-046013:0
15,000 shares@ US$1.898.4% of flowCommon StockSEC:0001209191-21-046013
15,000 shares@ US$1.890.0065% mcap8.1% of flowCommon StockSEC:0001209191-21-039261:0
15,000 shares@ US$1.898.1% of flowCommon StockSEC:0001209191-21-039261
15,000 shares@ US$1.890.0066% mcap8.2% of flowCommon StockSEC:0001209191-21-031248:0
15,000 shares@ US$1.898.2% of flowCommon StockSEC:0001209191-21-031248
195 sharesCommon StockSEC:0001493152-16-006551:0
41 sharesCommon StockSEC:0001493152-16-006551:1
19 of 19 declarations
About Mauro David J
David J. Mauro is the Chief Medical Officer at Prelude Therapeutics Inc. In this role, he oversees the company's medical and clinical initiatives. Mauro brings significant expertise in the medical field, contributing to innovation and the improvement of treatments.
